We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$5.49B
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.89%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$4.44B
AUM Growth
-$122M
(-2.7%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-17.33%
Top 10 Holdings %
Top 10 Hldgs %
66%
Holding
61
New
7
Increased
11
Reduced
20
Closed
12
Avg Time Held Equity + Options
9.2
quarters
Top 10 Avg Time Held Equity + Options
8.4
quarters
Top 20 Avg Time Held Equity + Options
7
quarters
Avg Time Held Equity only
9.8
quarters
Top 10 Avg Time Held Equity only
8.7
quarters
Top 20 Avg Time Held Equity only
7.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$76.5M |
| 2 |
Cigna
CI
|
+$56M |
| 3 |
Clarivate
CLVT
|
+$48.2M |
| 4 |
Corteva
CTVA
|
+$26.5M |
| 5 |
Warner Bros
WBD
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fiserv Inc
FISV
|
+$149M |
| 2 |
McKesson
MCK
|
+$101M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$64.5M |
| 4 |
Lennox International
LII
|
+$59.8M |
| 5 |
Tenet Healthcare
THC
|
+$56.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.66% |
| 2 | Technology | 19.2% |
| 3 | Miscellaneous | 16.53% |
| 4 | Materials | 7.49% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Cigna
CI
$74.7B
| $580M | 13.07% |
2,065,551
+214,918
| +12% | +$56M |
2013 Q2
40 quarters
|
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $532M | 11.99% |
1,200,000
+600
| +0.1% | +$252K |
2022 Q4
2 quarters
|
|
|
3
Tenet Healthcare
THC
$21.5B
| $526M | 11.87% |
6,468,798
-798,771
| -11% | -$56.9M |
2013 Q2
40 quarters
|
|
4
DXC Technology
DXC
$2.04B
| $260M | 5.86% |
9,734,411
+777,274
| +9% | +$19.4M |
2017 Q2
24 quarters
|
|
|
5
Universal Health Services
UHS
$10.6B
| $223M | 5.02% |
1,410,525
+548,422
| +64% | +$76.5M |
2022 Q4
2 quarters
|
|
6
Global Payments
GPN
$21.7B
| $221M | 4.98% |
2,244,174
| – | – |
2020 Q4
10 quarters
|
|
|
7
Clarivate
CLVT
$1.02B
| $165M | 3.72% |
17,315,445
+5,686,882
| +49% | +$48.2M |
2022 Q2
4 quarters
|
|
|
8
McKesson
MCK
$112B
| $162M | 3.64% |
378,193
-261,744
| -41% | -$101M |
2016 Q4
26 quarters
|
|
9
Alight
ALIT
$243M
| $139M | 3.14% |
754,860
+47,630
| +7% | +$8.45M |
2022 Q3
3 quarters
|
|
|
10
Corteva
CTVA
$8.91B
| $120M | 2.7% |
2,093,260
+454,052
| +28% | +$26.5M |
2019 Q4
14 quarters
|
|
11
PUT
iShares Russell 2000 ETF
IWM
$77.9B
| $112M | 2.53% |
+600,000
| New | +$107M |
2023 Q2
0 quarters
|
|
12
US Foods
USFD
$21.2B
| $112M | 2.53% |
2,553,354
-1,038,459
| -29% | -$41.2M |
2021 Q4
6 quarters
|
|
|
13
Fiserv Inc
FISV
$24.8B
| $111M | 2.51% |
881,068
-1,269,730
| -59% | -$149M |
2019 Q3
15 quarters
|
|
14
Valvoline
VVV
$3.85B
| $105M | 2.37% |
2,802,581
-1,000,368
| -26% | -$36.3M |
2022 Q1
5 quarters
|
|
15
FMC
FMC
$1.29B
| $88.9M | 2% |
852,243
+49,577
| +6% | +$5.57M |
2015 Q1
33 quarters
|
|
16
Myriad Genetics
MYGN
$390M
| $86.8M | 1.96% |
3,744,888
-450,224
| -11% | -$9.83M |
2019 Q3
15 quarters
|
|
17
Aptiv
APTV
$9.19B
| $84.5M | 1.91% |
827,937
-105,004
| -11% | -$10.4M |
2020 Q4
10 quarters
|
|
18
HCA Healthcare
HCA
$99.8B
| $80M | 1.8% |
263,624
-188,603
| -42% | -$52.4M |
2013 Q2
40 quarters
|
|
19
Brookdale Senior Living
BKD
$2.42B
| $78.7M | 1.77% |
18,644,673
| – | – |
2014 Q2
36 quarters
|
|
20
DuPont de Nemours
DD
$17.5B
| $74.5M | 1.68% |
830,286
-139,302
| -14% | -$12M |
2020 Q4
10 quarters
|
|
|
21
CALL
Cigna
CI
$74.7B
| $68.6M | 1.55% |
+244,500
| New | +$63.7M |
2023 Q2
0 quarters
|
|
22
Uber
UBER
$146B
| $67.3M | 1.52% |
1,558,119
-1,419,546
| -48% | -$52.8M |
2021 Q2
8 quarters
|
|
|
ATVI
23
DELISTED
Activision Blizzard
ATVI
| $57.6M | 1.3% |
683,849
-154,813
| -18% | -$12.5M |
2021 Q4
6 quarters
|
|
24
Element Solutions
ESI
$9.07B
| $48.9M | 1.1% |
2,546,619
-477,710
| -16% | -$8.78M |
2016 Q3
27 quarters
|
|
25
Expedia Group
EXPE
$32.8B
| $41.9M | 0.94% |
383,038
| – | – |
2022 Q3
3 quarters
|
|
Similar funds
GCM
VCM
ACM
MC
SCM
NC
EI
AP
Glenview Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Glenview Capital Management held 61 positions worth $4.44B, down 2.7% from $4.56B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Glenview Capital Management withdrew a net $769M in Q2 2023, closing 12 positions and reducing 20 holdings. Its most notable exit was Lennox International, an estimated $59.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Glenview Capital Management opened a new position in Warner Bros worth $20.4M.
- Glenview Capital Management's largest Q2 2023 buy was Warner Bros: 1,624,300 shares worth $20.4M.
- Glenview Capital Management added most to Universal Health Services in Q2 2023, an estimated $76.5M increase.
- Glenview Capital Management's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $149M.
- Glenview Capital Management fully exited Lennox International in Q2 2023, selling an estimated $59.8M.
- Glenview Capital Management's ten largest holdings make up 66% of its $4.44B portfolio in Q2 2023.
- Glenview Capital Management opened 7 new positions and closed 12 in Q2 2023.
- Glenview Capital Management's portfolio value fell 2.7% quarter-over-quarter to $4.44B.
Based on Glenview Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.